Search Results for “L3M2 Studienmaterialien: Ethical Procurement and Supply – L3M2 Torrent Prüfung – L3M2 wirkliche Prüfung 🍱 Suchen Sie auf （ www.itzert.com ） nach 《 L3M2 》 und erhalten Sie den kostenlosen Download mühelos 🙁L3M2 Prüfungs-Guide” – Page 38

Mast cell functions in the innate skin immune system

26.	Metz, M., Siebenhaar, F. and Maurer, M.: Mast cell functions in the innate skin immune system. Immunobiology 2008: 213; 251-260. IF: 3.46

The definition, acronyms, nomenclature, and classification of angioedema: AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus

602.

Reshef, A.⁺, Buttgereit, T., Betschel, S. D., Caballero, T., Farkas, H., Grumach, A. S., Hide, M., Jindal, A. K., Longhurst, H., Peter, J., Riedl, M. A., Zhi, Y., Aberer, W., Abuzakouk, M., Al Farsi, T., Al Sukaiti, N., Al-Ahmad, M., Altrichter, S., Aygören-Pürsün, E., Baeza, M. L., Bara, N. A., Bauer, A., Bernstein, J. A., Boccon-Gibod, I., Bonnekoh, H., Bouillet, L., Brzoza, Z., Bygum, A., Calderon, O., de Albuquerque Campos, R., Campos Romero, F. H., Cancian, M., Chong-Neto, H. J., Christoff, G., Cimbollek, S., Cohn, D. M., Craig, T., Danilycheva, I., Darlenski, R., Du-Thanh, A., Ensina, L. F., Fomina, D., Fonacier, L., Fukunaga, A., Gelincik, A., Giavina-Bianchi, P., Godse, K., Gompels, M., Goncalo, M., Gotua, M., Guidos-Fogelbach, G., Guilarte, M., Kasperska-Zajac, A., Katelaris, C. H., Kinaciyan, T., Kolkhir, P., Kulthanan, K., Kurowski, M., Latysheva, E., Lauerma, A., Launay, D., Lleonhart, R., Lumry, W., Malbran, A., Ali, R. M., Nasr, I., Nieto-Martinez, S., Parisi, C., Pawankar, R., Piñero-Saavedra, M., Popov, T. A., Porebski, G., Prieto Garcia, A., Pyatilova, P., Rudenko, M., Sekerel, B. E., Serpa, F. S., Sheikh, F., Siebenhaar, F., Soria, A., Staevska, M., Staubach, P., Stobiecki, M., Thomsen, S. F., Triggiani, M., Valerieva, A., Valle, S., Van Dinh, N., Vera Ayala, C. E., Zalewska-Janowska, A., Zanichelli, A., Magerl, M., and Maurer, M.: The definition, acronyms, nomenclature, and classification of angioedema: AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus. J. Allergy Clin. Immunol. 2024: 154; 398-411. IF: TBD (IF 2023: 11.40)

o.602

119	Weller, K., Church, M. K., Kalogeromitros, D., Krause, K., Magerl, M., Metz, M., Pisarevskaja, D., Siebenhaar, F., and Maurer, M.+: Chronic spontaneous urticaria – how to assess quality of life in patients receiving treatment. Arch. Dermatol. 2011: 147; 1221-1223. IF: 3.88

Disease modification in chronic spontaneous urticaria

606.

Maurer, M.⁺, Kolkhir, P.^*, Pereira, M. P.^*, Siebenhaar, F.^*, Witte-Händel, E., Bergmann, K.-C., Bonnekoh, H., Buttgereit, T., Fluhr, J. W., Frischbutter, S., Grekowitz, E. M., Herzog, L., Kiefer, L. A., Krause, K., Magerl, M., Muñoz, M., Neisinger, S., Nojarov, N., Prins, S., Pyatilova, P., Ramanauskaite, A., Scheffel, J., Terhorst-Molawi, D., Treudler, R., Weller, K., Zuberbier, T., and Metz, M.: Disease modification in chronic spontaneous urticaria. Allergy 2024: 79; 2396-2413. IF: TBD (IF 2023: 12.60)

o.606

193.	Terhorst-Molawi, D., Fox, L., Siebenhaar, F., Metz, M., and Maurer, M.⁺: Stepping down treatment in chronic spontaneous urticaria – what we know and what we don‘t know. Am. J. Clin. Dermatol. 2023: 24; 397-404. IF: 8.60

r.193

116.	Weller, K., Siebenhaar, F., Hawro, T., Altrichter, S., Schoepke, N., and Maurer, M.: Clinical measures of chronic urticaria. Immunol. Allergy Clin. North Am. 2017: 37; 35-49. IF: 3.69

r.116

Development of tripe palms and soles in a patient with long pre-existing systemic mastocytosis and newly developed non-small cell lung cancer

306

Bonnekoh, H., Ohanyan, T., Lenze, D., Krause, K., Maurer, M. Zuberbier, T.*, and Siebenhaar, F.*+: Development of tripe palms and soles in a patient with long pre-existing systemic mastocytosis and newly developed non-small cell lung cancer. J. Eur. Acad. Dermatol. Venereol. 2018: 32; e151-e153. IF: 5.11

530.	Hackler, Y., Siebenhaar, F., Maurer, M., and Muñoz-Roldan, M.⁺: Virus-infected mast cells directly activate virus-specific CD8⁺ T cells. Scand. J. Immunol. 2023: 98; e13272. IF: 4.10

o.530

Avapritinib versus placebo in indolent systemic mastocytosis

534.

Gotlib, J.^+*, Castells, M.^+*, Oude Elberink, H., Siebenhaar, F., Hartmann, K., Broesby-Olsen, S., George, T. I., Panse, J., Alvarez-Twose, I., Radia, D. H., Tashi, T., Bulai Livideanu, C., Sabato, V., Heaney, M., van Daele, P., Cerquozzi, S., Dybedal, I., Reiter, A., Pongdee, T., Barete, S., Ustun, C., Schwartz, L., Ward, B. R., Schafhausen, P., Vadas, P., Bose, P., DeAngelo, D. J., Rein, L., Vachhani, P., Triggiani, M., Bonadonna, P., Rafferty, M., Butt, N. M., Oh, S. T., Wortmann, F., Ungerstedt, J., Guilarte, M., Taparia, M., Kuykendall, A. T., Yi, C. A., Ogbogu, P., Gaudy-Marqueste, C., Mattsson, M., Shomali, W., Giannetti, M. P., Bidollari, I., Lin, H.-M., Sullivan, E., Mar, B., Scherber, R., Roche, M., Akin, C., and Maurer, M.: Avapritinib versus placebo in indolent systemic mastocytosis. NEJM Evid. 2023: 2. IF: N/A

o.534

91.	Siebenhaar, F., Falcone, F. H., Tiligada, E., Hammel, I., Maurer, M., Sagi-Eisenberg, R., and Levi-Schaffer, F.: The search for mast cell and basophil models – are we getting closer to pathophysiological relevance? Allergy 2015: 70; 1-5. IF: 6.33

Results